0001209191-11-031507.txt : 20110527 0001209191-11-031507.hdr.sgml : 20110527 20110527135138 ACCESSION NUMBER: 0001209191-11-031507 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110527 FILED AS OF DATE: 20110527 DATE AS OF CHANGE: 20110527 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: XANTHOPOULOS KLEANTHIS G CENTRAL INDEX KEY: 0001283304 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50632 FILM NUMBER: 11877504 MAIL ADDRESS: STREET 1: 9050 CAMINO SANTA FE CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ANADYS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001128495 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 223193172 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5871 OBERLIN DRIVE, SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8585303600 MAIL ADDRESS: STREET 1: 5871 OBERLIN DRIVE, SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 doc4.xml FORM 4 SUBMISSION X0303 4 2011-05-27 0 0001128495 ANADYS PHARMACEUTICALS INC ANDS 0001283304 XANTHOPOULOS KLEANTHIS G C/O ANADYS PHARMACEUTICALS, INC. 5871 OBERLIN DRIVE, SUITE 200 SAN DIEGO CA 92121 1 0 0 0 Stock Option (Right to Buy) 1.17 2011-05-27 4 A 0 15000 0.00 A 2011-06-27 2021-05-26 Common Stock 15000 15000 D Non-discretionary grant pursuant to the Company's 2004 Non-Employee Directors' Stock Option Plan. 1/12th of the shares subject to this option shall vest and become exercisable monthly over a one year period. /s/ Elizabeth E. Reed, as Attorney-in-Fact for Kleanthis G. Xanthopoulos, Ph.D. 2011-05-27